• DOI:10.1089/ars.2017.7065
Corpus ID: 196634438

Twenty-First Century Diseases: Commonly Rare and Rarely Common?

@article{Daunert2017TwentyFirstCD,
  title={Twenty-First Century Diseases: Commonly Rare and Rarely Common?},
  author={S. Daunert and G. Sittampalam and P. Goldschmidt-Clermont},
  journal={Antioxidants & redox signaling},
  year={2017},
  volume={27 9},
  pages={
          511-516
        }
}

S. Daunert, G. Sittampalam, P. Goldschmidt-Clermont

Published 2017

Biology, Medicine

Antioxidants & redox signaling

Alzheimer's drugs are failing at a rate of 99.6%, and success rate for drugs designed to help patients with this form of dementia is 47 times less than for drugs designed to help patients with cancers ( www.scientificamerican.com/article/why-alzheimer-s-drugs-keep-failing/2014 ). How can it be so difficult to produce a valuable drug for Alzheimer's disease? Each human has a unique genetic and epigenetic makeup, thus endowing individuals with a highly unique complement of genes, polymorphisms… CONTINUE READING

View on PubMed

liebertpub.com

Save to Library

Create Alert

Cite

Launch Research Feed